Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459901
Status:
TERMINATED
Last Update Posted:
2015-04-29
First Post:
2007-04-11
Brief Title:
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer
Sponsor:
Peter Kozuch
Organization:
Beth Israel Medical Center
Organization Data
Organization:
Beth Israel Medical Center
Class:
OTHER
Study ID:
022-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peter Kozuch
Lead Sponsor Class:
OTHER
Responsible Party:
Peter Kozuch
Responsible Party Title:
Attending
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Beth Israel Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| Hoffmann-La Roche | INDUSTRY |